Seeking Alpha

QualityStocks'  Instablog

Send Message
QualityStocks ( assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with... More
My company:
My blog:
QualityStocks Micro-Cap and Small-Cap Blog
  • International Stem Cell Corp. (ISCO) Gives Lifeline Skin Care The Winning Edge 0 comments
    Apr 29, 2013 3:14 PM | about stocks: ISCO

    On the Lifeline Skin Care website ( it says "Someday, stem cells will change the world. Today, stem cells will change your skin." Lifeline Skin Care, a subsidiary of International Stem Cell Corp., produces stem cell based skin care products, leveraging technology only available through its association with ISCO. Although the application of stem cells and their regeneration properties to skin rejuvenation has been heavily popularized, Lifeline Skin Care's offerings are unique.

    Specifically, Lifeline stem cell creams are the only products in the world that contain human, non-embryonic stem cell extracts. This is possible because of ISCO's development of parthenogenesis, the ability to generate true pluripotent stem cells without the use of a fertilized human embryo. It's a one-of-a-kind technology that not only avoids the ethical issues common to stem cell application, but also results in stem cells that can be immune-matched to millions of people, avoiding the use of immuno-suppression drugs. ISCO scientists are focused on using these stem cells to treat severe diseases of the eye, the nervous system, and the liver, where cell therapy has been proven clinically yet is limited by the availability of safe immune-matched human cells.

    Lifeline skin care is focused on the application of this technology to skin rejuvenation, combining stem cell biology, nanotechnology, and skin cream formulation technology to produce the highest quality, scientifically tested, and most effective anti-aging products available. The company does not license the brand name, the technology, the stem cell extracts, or proprietary ingredients to any other company. Moreover, revenues from Lifeline Skin Care help fund stem cell research for curing regenerative diseases like diabetes and Parkinson's Disease.

    However, to end users, the real life effectiveness of the product is most important, and is backed up by an independent clinical study showing 63% improved skin tone and brightness, 67% decreased wrinkles appearance, 73% increased skin elasticity, and 93% improved skin hydration.

    For additional information, visit

    Please see disclaimer on the QualityStocks website:

    Stocks: ISCO
Back To QualityStocks' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.